NEWS - Nov 12, 2015 Relmada Therapeutics Strengthens its Board of Directors with the Appointment of Maged Shenouda and Paul Kelly Read more
NEWS - Sep 23, 2015 Relmada Therapeutics to Present at Ladenburg Thalmann 2015 Healthcare Conference Read more
NEWS - Sep 9, 2015 Relmada Therapeutics Announces Issuance of U.S. Patent Covering SECUREL™ - an Abuse-Deterrent, Extended-Release, Technology Platform for Opioids Read more
NEWS - Sep 2, 2015 Relmada Therapeutics to Participate in Two Upcoming Investor Conferences Read more
NEWS - Aug 17, 2015 Relmada Therapeutics Receives Health Canada Clearance to Commence Multiple Ascending Dose Study with Promising NMDA Receptor Antagonist Read more
